CHU de Besançon
Besançon, 25000, France
NCT Number: NCT03312166
SCARWARS study deals with the first on-human evaluation of a compressive device dedicated to the prevention of keloïd scars recurrence after surgery. The tested device is made with clinical grade silicon. SCARWARS is a monocentric study. 27 patients will be include and follow during one year. The primary outcome of this study is the number of keloid recurrence after treatment.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Besançon, 25000, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
interventions on patient are :
Time frame: 12 month
Recurrence will be assessed during each visit by surgeon
Centre Hospitalier Universitaire de Besancon
Other
First Study Evaluating Efficiency and Safety of a Compressive Device to Prevent Keloid Scars Recurrence After Surgery
Acronym: SCARWARS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07673484
Allergic Contact Dermatitis, Cicatrix
Küçükçekmece, Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07420166
Cicatrix, Collagen Diseases
Bahawalpur, Punjab Province, Pakistan
View Trial DetailsNCT07263100
Cicatrix, Cicatrix, Hypertrophic
Sattahip, Changwat Chon Buri, Thailand
View Trial DetailsNCT05330078
Cicatrix, Collagen Diseases
San Diego, California, United States
View Trial Details